Navigation Links
Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
Date:7/29/2008

- Unsuccessful Phase III Study Does Not Mean the End of Anti-Amyloid Therapies -

CHICAGO, July 29 /PRNewswire-USNewswire/ -- Results from four studies of potential new treatments for Alzheimer's - even an unsuccessful late stage clinical trial - increase the field's knowledge and point scientists toward advances in therapies for the disease, according to research reported today at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD 2008), in Chicago.

The reports included data from:

-- A Phase III trial of tarenflurbil (Flurizan, Myriad), an anti-amyloid therapy, that failed to achieve its primary endpoints.

-- A 12-week, Phase IIa trial of PBT2 (Prana Biotechnology), which reduces the toxic form of amyloid by preventing the interaction of amyloid with copper and zinc in the brain.

-- A 84-week, Phase II trial of methylthioninium chloride (rember(TM), TauRx Therapeutics), a tau aggregation inhibitor that targets toxic tau aggregates, or "tangles." Tangles of tau in the brain are another characteristic hallmark of Alzheimer's.

-- A proof of concept clinical trial in mild Alzheimer's of Souvenaid (Danone Research-Centre for Specialised Nutrition), a "medical food" product that encourages the formation of brain synapses and may reduce beta amyloid.

"While researchers continue to investigate amyloid as a target for Alzheimer's therapies - it is the most mature theory being pursued - we must also examine other potential avenues given the urgency of conquering this disease," said Samuel Gandy, MD, Ph.D., chair of the Alzheimer's Association's Medical and Scientific Advisory Council. "We can't leave any stone unturned if we hope to aid the 5 million people currently living with Alzheimer's and the millions more that will be devastated by this epidemic."

While currently approved treatment options for Alzheimer's offer some relief of symptoms for perhaps a year or two, they do no
'/>"/>

SOURCE Alzheimer's Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
2. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
5. Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
6. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
7. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
8. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
9. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
10. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
11. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)...  The management team at Columbia Laboratories, Inc. ... conference call on July 31, 2014, to discuss ... 30, 2014.  The call details are as follows:Date: ... EDTDial-in numbers: , Toll free: (877) 870-4263 (U.S.), ... archive): , www.columbialabs.com , under ,Investor, or ...
(Date:7/23/2014)... July 23, 2014 Global healthcare ... is facing currency headwinds, increased price competition and supply ... Andrew Witty points out that the company is ... as reason to be confident about long-term prospects as ... growth. CFO Simon Dingemans adds ...
(Date:7/23/2014)... DUBLIN , July 23, 2014 ... addition of the "Prepackaged Medical Kits and ... to their offering. ... worldwide markets for Prepackaged Medical Kits and Trays ... ENT Custom Trays, Ophthalmic Custom Trays, Custom Basin ...
Breaking Medicine Technology:Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2
... 20 Today, Family Research,Council President Tony Perkins ... Shinya Yamanaka. Thomson, the first to grow human ... in the journals Science,and Cell, respectively, showing that ... human skin cells, without first creating or,destroying human ...
... International,Corporation (Nasdaq: PRXL ), a ... Dr. Victor Kiri, formerly with GlaxoSmithKline,as ... Clinical Research,Services business. Dr. Kiri,s responsibilities ... conduct of comparative observational studies, offering,epidemiological ...
Cached Medicine Technology:PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 2PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 3PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 4
(Date:7/23/2014)... 23, 2014 Olympic gold medal-winning speed ... Virginia on Friday, July 18. Hedrick visited Roanoke as ... Commonwealth Games, an Olympic-style event celebrating its 25th Anniversary ... as a premier sponsor of the Commonwealth Games, which ... all ages and all activity levels. , Hedrick, a ...
(Date:7/23/2014)... not be the sole domain of humans, with new ... comes to the love of their master. When ... stuffed dog, the real puppies in the study responded ... researchers from the University of California, San Diego (UCSD). ... attending to the stuffed dog and not when they ...
(Date:7/23/2014)... HealthDay Reporter WEDNESDAY, July 23, ... menstrual period may be determined by hundreds, and possibly thousands, ... have identified over 100 regions of DNA that are connected ... period. The researchers hope these findings will shed light on ... 2 diabetes to breast cancer. "These findings will provide ...
(Date:7/23/2014)... of the genome resulting from a combination of genetic ... or weak predispositions to developing certain kinds of cancer; ... cells throughout our lifetime. Although the genetic origins of ... were not able to measure the role of non-coding ... geneticists from the University of Geneva (UNIGE), by studying ...
(Date:7/23/2014)... Texas Physical Therapy Specialists (TexPTS) is proud ... Westgate, Liberty Hill, Parmer, Balcones, and Georgetown clinics have ... Orthopaedic Certified Specialist (OCS) or Sports Certified ... OCS, Tony Lauretta, PT, DPT, OCS, Jason Brown, PT, ... PT, DPT, OCS, and Mary Grimberg, PT, DPT, OCS ...
Breaking Medicine News(10 mins):Health News:US Olympian Chad Hedrick Visits Foot Levelers 2Health News:Dogs Can Get Jealous, Too 2Health News:Gene Study Gives New Insight Into Puberty in Girls 2Health News:Gene Study Gives New Insight Into Puberty in Girls 3Health News:Genetics of cancer: Non-coding DNA can finally be decoded 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3
... , GAINESVILLE, Fla. , ... Shands HealthCare announce today that they have jointly selected Sg2 ... Gainesville -based children,s hospital. The assessment began in January with findings ... that the experts at Sg2 will handle this very important ...
... , , CONCORD, Mass. , ... sworn off tanning booths. An avid tanner, Saley recently got a ... story. Saley had gone to a Melanoma Foundation of New England ... went through an agonizingly painful operation that resulted in eight lymph ...
... ... Babinec creates Upstate Venture Connect (UVC), a not-for-profit organization that seeks to accelerate ... entrepreneurs, investors and venture talent to establish a large number of small, innovation-oriented ... ...
... But experts disagree over whether to continue using them ... Patients suffering from chronic obstructive pulmonary disease (COPD) are ... the disease, but a new study finds these drugs ... corticosteroids have been widely prescribed to help treat the ...
... , HAMILTON, Bermuda , Feb. 4 ... "Company") today announced that Chief Executive,Officer Michael S. McGavick is ... Mandarin Oriental Hotel in Miami, Florida ,on Thursday, February 11, ... A live webcast of Mr. McGavick,s presentation will be available via, ...
... Va. An assistant professor with the Virginia Tech ... to formulate a mathematical framework that can track the ... computer networks, as well as how a blackout occurring ... of additional neighboring networks to fail. Funded by ...
Cached Medicine News:Health News:Sebastian Ferrero Foundation and Shands HealthCare Have Selected Sg2 to Conduct a Needs Assessment for a Gainesville-Based Children's Hospital 2Health News:Sebastian Ferrero Foundation and Shands HealthCare Have Selected Sg2 to Conduct a Needs Assessment for a Gainesville-Based Children's Hospital 3Health News:High School and College Students Take No-Tanning Pledge to Stay out of Tanning Beds for Proms and Spring Break 2Health News:High School and College Students Take No-Tanning Pledge to Stay out of Tanning Beds for Proms and Spring Break 3Health News:Silicon Valley Entrepreneur Launches Startup to Accelerate Tech Entrepreneurship in Upstate New York 2Health News:Silicon Valley Entrepreneur Launches Startup to Accelerate Tech Entrepreneurship in Upstate New York 3Health News:Silicon Valley Entrepreneur Launches Startup to Accelerate Tech Entrepreneurship in Upstate New York 4Health News:Silicon Valley Entrepreneur Launches Startup to Accelerate Tech Entrepreneurship in Upstate New York 5Health News:Steroids May Be Overrated in Treatment of COPD 2Health News:Steroids May Be Overrated in Treatment of COPD 3Health News:XL Capital Ltd to Present at Credit Suisse Financial Services Forum on February 11, 2010 2Health News:Researcher to track spread of disease, malware and power outages 2
Monitorr ICP external CSF drainage system with self-contained ICP setting....
... Sophysa external neurological drainage system combines ... all the essential functions for CSF ... technological solutions contribute to make this ... is available as a single item ...
... for neuro and skull base surgery. ... craniofacial surgery, pediatric neurosurgery, bony defects ... skull base regions, neuro trauma. Dedicated ... implants in one compact kit. MRI ...
14 cm - 5 1/2, 6.0 mm , for drill handles and hand drills....
Medicine Products: